Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Jouleh (Bergen, Norway), I. Haaland (Bergen, Norway), F. Khorsand (Bergen, Norway), R. Sandvik (Bergen, Norway), T. Kalananthan (Bergen, Norway), R. Nielsen (Bergen, Norway), T. Jouleh (Bergen, Norway), H. Wiker (Bergen, Norway), P. Bakke (Bergen, Norway), N. Reuter (Bergen, Norway), T. Eagan (Bergen, Norway). Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD. 2291

Member's Comments

No comment yet.

Related content which might interest you: Elevation of neutrophil collagenase (MMP-8) and elastase during COPD exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 PP102 – A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF Source: ERS Lung Science Conference 2021 Year: 2021 Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Elevated level of tissue inhibitor of metalloproteinase 1 in bronchoalveolar lavage fluid in fibrosing lung diseases Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002 Increased levels of human myeloperxidase (MPO) and neutrophil lipocalin (HNL/NGAL) in childhood asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation Source: Eur Respir J 2003; 22: 739-742 Year: 2003 Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema Source: Eur Respir J 2002; 19: 1050-1057 Year: 2002 Decreased levels of secretory leucoprotease inhibitor in the pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005 The influence of steroidotherapy in COPD exacerbation on matrix metalloproteinase MMP-9 level in BAL, induced sputum and serum Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Determination of IL-8 concentration and the activity of β-glucuronidase in BAL samples in children with inflammatory lung disease Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010 Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease Year: 2003 Increased activin-a expression in serum, BAL and bronchial tissue of asthmatic patients Source: Annual Congress 2009 - Novel approaches in asthma Year: 2009 Differences in nasal fluid levels of myeloperoxidase (MPO) and fucose after lavage with saline and histamine solutions, respectively, may indicate a neutrophil inflammation in the nasal mucosa in patients with COPD, and moreover, a glandular Source: Eur Respir J 2002; 20: Suppl. 38, 93s Year: 2002 Elevated levels of BALF galectin-9 in patients with interstitial pneumonia Source: Annual Congress 2009 - Airways remodelling Year: 2009 Neutrophil elastase and IL-8 assessment in patients with COPD and asthma Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005 Increased gelatinase and collagenase activity in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Chitotriosidase as a possible marker of sarcoidosis activity Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Lymphocyte and macrophage apoptosis in bronchoalveolar lavage fluid (BALF) of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 749s Year: 2006